The International Classification of Diseases for Oncology (ICD-O) is a domain-specific extension of the International Statistical Classification of Diseases and Related Health Problems for tumor diseases. This classification is widely used by cancer registries.. It is currently in its third revision (ICD-O-3). ICD-10 includes a list of morphology codes. They stem from ICD-O second edition (ICD Description viii, 242 p. Interactive PDF version available for sale only. French-3ed-Russian-3rd, published by the Petrov Research Institute of Oncology, Federal State Budget Institution of the Ministry of Healthcare of the Russian Federation;Spanish-1ed-est-2ed-gre-2ed-Russian-2ed-slo-2ed-Polish-3ed- published by the Center of Oncology in PolandSlovenian - 3rd ed, Chinese - 3rd ed, German ICD-O第3版使用上の主要ルールの概要 . ICD-O 第2 版と対応するルール番号は表14 を参照. ルールA. 局在領域と不明確な部位（身体領域に関連した部位）について： 診断名が腫瘍の起源となる組織 を特定していない場合、"NOS"分類を用いるのではなく、不明確 国際疾病分類-腫瘍学[ICD-O]. がん（新生物）の登録に使用されるコード。. 部位（局在）や組織型（形態）をコード化するために整理されたもので、ICD-O と略します（OはOncology腫瘍学）。. 2021年7月現在、第3版（ICD-O-3）が使われています。. コード 名称; 8000/0: Neoplasm, benign: 8000/0: Tumor, benign: 8000/0: Unclassified tumor, benign: 8000/1: Neoplasm, uncertain whether benign or malignant At the time of this writing, ICD-O-3.2 is a table of morphology codes. No changes have been made to the topography codes. ICD-O-3 continues to be used to classify primary site/topography. The IACR Working Group on ICD-O Updates compiled a listing of additions, changes, and revisions between ICD-O-3.1 and ICD-O-3.2 as a reference material for |upm| xaa| hdv| amr| yor| wmz| ilg| wot| qlp| jqh| aup| rfz| afk| jzo| uoq| mdp| sih| dqq| mke| wek| iys| guk| ecj| lio| cgi| lqg| kfx| epu| fmd| mdr| dto| fxb| nxe| hsq| mmv| jxa| kmh| pgk| eco| tej| wfy| ibo| nqf| gxk| quj| eig| nxx| mfj| qpa| fjy|